Generated by AI
Summary of Sep 18's posts. Generated by AI.
Summary of Sep 18's posts. Generated by AI.
Summary of Feb 1's posts. Generated by AI.
Summary of Sep 18's posts. Generated by AI.
Investors talking about AEMD also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.
Aethlon Medical, Inc. is a medical therapeutic company focused on developing immunotherapeutic technologies for oncology and infectious disease. Its lead product, the Hemopurifier, is a clinical-stage extracorporeal device designed to remove circulating disease-related targets from blood and other biologic fluids. The company’s work spans applications in cancer care, life-threatening viral infections, and organ transplantation, with a broader emphasis on addressing unmet needs in medical treatment and biodefense. Aethlon Medical combines device-based therapy and filtration science to support clinical research in areas where current options remain limited. Headquartered in San Diego, California, the company operates as a specialized player in the healthcare sector, concentrating on advanced therapeutic devices rather than broad pharmaceutical products.
Website11555 Sorrento Valley Road
San Diego, CA, 92121
United States
The latest articles about AEMD.
Detailed price information for Aethlon Medical Inc (AEMD-Q) from The Globe and Mail including charting and trades.
Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.
North Immunology will emerge into the public biotech world through a reverse merger with Aethlon Medical (AEMD).